High-Dose Prednisolone for Treatment of Infantile Spasms After Presumed Perinatal Stroke

Insights

High-dose prednisolone effectively treated infantile spasms in a child with perinatal stroke, leading to seizure freedom and developmental progress. This suggests it may be a viable first-line therapy for similar cases.

Area of Science:

  • Pediatric Neurology
  • Neonatal Neurology
  • Pediatric Stroke

Background:

  • Infantile spasms (IS) are a severe epilepsy syndrome in infants.
  • High-dose corticosteroids are used for IS, but efficacy in IS secondary to perinatal stroke is less understood.
  • Perinatal stroke is a known cause of IS, often associated with cerebral palsy.

Purpose of the Study:

  • To evaluate the efficacy and safety of high-dose prednisolone as a first-line treatment for infantile spasms in a child with perinatal stroke.
  • To assess the impact of treatment on seizure control and neurodevelopmental outcomes.

Main Methods:

  • A single case study of a 9-month-old girl with new-onset infantile spasms secondary to a perinatal left middle cerebral artery stroke.
  • Diagnosis confirmed by video-electroencephalography (EEG) showing modified hypsarrhythmia.
  • Treatment with high-dose prednisolone (8 mg/kg/day) for 2 weeks, followed by a 5-week taper.

Main Results:

  • The patient became seizure-free after the first dose of prednisolone.
  • EEG after treatment completion showed resolution of modified hypsarrhythmia and no epileptiform discharges.
  • No significant adverse effects were observed during prednisolone therapy.
  • The child maintained excellent developmental progress during and after treatment.

Conclusions:

  • High-dose prednisolone may be an effective and safe first-line therapy for infantile spasms associated with perinatal stroke.
  • This case highlights the potential of corticosteroids in managing IS in this specific etiology.
  • Further research is warranted to confirm these findings in a larger cohort.